The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer

被引:25
|
作者
Chen, Sufeng [1 ]
Zhang, Jie [1 ]
Li, Xuebing [2 ]
Luo, Xiaoyang [1 ]
Fang, Jing [2 ]
Chen, Haiquan [1 ]
机构
[1] Fudan Univ, Canc Hosp, Inst Canc, Dept Thorac Surg, Shanghai 200032, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
Apoptosis; Bax; Bcl-2; Non-small cell lung cancer; Prolyl hydroxylases; HYPOXIA-INDUCIBLE-FACTOR; ENDOTHELIAL GROWTH-FACTOR; HIF; PROTEIN; APOPTOSIS; FAMILY; ACTIVATION; PHYSIOLOGY; ALPHA; PHD3;
D O I
10.1007/s11010-011-0976-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prolyl hydroxylase domain enzymes (PHDs) play the most notable role in cellular oxygen sensing and oxygen homeostasis, the transcription of PHD genes are involved in the protection against hypoxia and oxidative stress. Intratumoral hypoxia exists in malignant solid tumors primarily due to rapid cancer cell proliferation with high metabolic demands and defective structural and functional vasculature. Previous studies have demonstrated that all the three PHDs have the ability to hydroxylate hypoxia inducible factor (HIF) polypeptides, which are the key molecules in maintaining the oxygen homeostasis. However, PHDs play multiple physiological and pathological roles. There is scant data regarding expression of PHDs genes in non-small cell lung cancer (NSCLC) tissues. In Addition, the relationship between PHDs and apoptosis has never been explored in NSCLC. In this article, we examined the expression of PHD genes and their relationship with the tumor behavior and apoptosis-associated factors in NSCLC. Our results indicated that the expression of PHDs was much higher in lung cancer tissue than that of adjacent normal tissue, and the high expression of PHD3 was associated with early tumor stage and well differentiation in NSCLC. Moreover, increased PHD3 expression was significantly correlated with the low expression of Bcl-2, suggesting its potential role in inducing apoptosis.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 50 条
  • [21] Intense bcl-2 immunostaining confers a poor prognosis in non-small cell lung cancer
    Cox, G
    Walker, R
    O'Byrne, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A202 - A202
  • [22] Bcl-2 family in non-small cell lung cancer: its prognostic and therapeutic implications
    Sun, Ping-Li
    Sasano, Hironobu
    Gao, Hongwen
    PATHOLOGY INTERNATIONAL, 2017, 67 (03) : 121 - 130
  • [23] BAX, BCL-2 AND C-KIT expression in non-small cell lung cancer amd their effects on prognosis
    Yaren, A
    Oztop, I
    Kargi, A
    Ulukus, C
    Yilmaz, U
    Onen, A
    Sanli, A
    Akkoclu, A
    Alakavuklar, M
    LUNG CANCER, 2005, 49 : S97 - S98
  • [24] The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer
    Gregorc, V
    Darwish, S
    Ludovini, V
    Pistola, L
    De Angelis, V
    Mihaylova, Z
    Bellezza, G
    Sidoni, A
    Cavaliere, A
    Bucciarelli, E
    Massaro, G
    Tonato, M
    LUNG CANCER, 2003, 42 (03) : 275 - 281
  • [25] Expression of phase I enzymes in non-small cell lung cancer
    Oyama, Tsunehiro
    Sugio, Kenji
    Uramoto, Hidetaka
    Hanagiri, Takeshi
    Nozoe, Tadahiro
    Sugaya, Masakazu
    Ono, Kenji
    Nakata, Shoji
    Ichiki, Yoshinobu
    So, Tetsuya
    Mizukami, Makiko
    Fukuyama, Takashi
    Baba, Tetsuro
    Isse, Toyohi
    Kawamoto, Toshihiro
    Yasumoto, Kosei
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Expression of prolyl 4-hydroxylase beta-polypeptide in non-small cell lung cancer treated with Chinese medicines
    Shu-mei Wang
    Li-zhu Lin
    Dai-han Zhou
    Jing-xu Zhou
    Shao-quan Xiong
    Chinese Journal of Integrative Medicine, 2015, 21 : 689 - 696
  • [27] Expression of Prolyl 4-Hydroxylase Beta-Polypeptide in Non-Small Cell Lung Cancer Treated with Chinese Medicines
    Wang Shu-mei
    Lin Li-zhu
    Zhou Dai-han
    Zhou Jing-xu
    Xiong Shao-quan
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2015, 21 (09) : 689 - 696
  • [28] Expression of Prolyl 4-Hydroxylase Beta-Polypeptide in Non-Small Cell Lung Cancer Treated with Chinese Medicines
    王淑美
    林丽珠
    周岱翰
    周京旭
    熊绍权
    Chinese Journal of Integrative Medicine, 2015, 21 (09) : 689 - 696
  • [29] Expression of Prolyl 4-Hydroxylase Beta-Polypeptide in Non-Small Cell Lung Cancer Treated with Chinese Medicines
    王淑美
    林丽珠
    周岱翰
    周京旭
    熊绍权
    Chinese Journal of Integrative Medicine , 2015, (09) : 689 - 696
  • [30] Up-regulated GGA3 promotes non-small cell lung cancer proliferation by regulating TrkA receptor
    Jiang, Bo-Gang
    Zhou, Yan-Rong
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (07) : 2543 - 2551